KLK3 and benign prostatic hyperplasia: Through a well validated chromatographic method, urinary Spm had been shown to possess usefulness in differentiating PCa from non-cancerous cases including BPH, and it could help to act as a secondary screening tool to serum PSA test to address its high false-positive rate when using 4.0ng/ml as a cut-off point.